Founded in 2007, Kuecept Ltd is a specialist contract research organization providing early-stage formulation development and drug substance characterisation services to the pharmaceutical, biotech and healthcare industries.
We specialise in improving the oral bioavailability of BCS II / IV compounds through the application of enabling solubilisation technologies and can support oral and parenteral dosage form design and development activities from concept to fclinic.
An extension of your own company's R&D team
Differentiated by our scientific focus and our client-centric services, Kuecept is committed to fostering collaborative relationships with our customers. This approach delivers solutions that benefit from collective insight and knowledge and keeps us focused on the goal of successfully moving your drug candidate through development. In addition, by providing high quality, flexible services with fast turn-around at cost-effective pricing, Kuecept is rapidly becoming the partner of choice in the field of early-stage drug development for many pharmaceutical companies.